Fund Holdings — New Leaf Venture Partners, L.L.C.

Total Portfolio Value:
$74.80M
Total Bought:
$4.94M
Total Sold:
$14.19M
Net Transaction:
-$9.25M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Arvinas, Inc.(ARVN)1,434,7211,585,721+151,000$35.34M$30.40M40.64%-$4.94M
Edgewise Therapeutics, Inc.(EWTX)1,553,6611,030,161-523,500$41.47M$27.51M36.77%-$13.96M
Crinetics Pharmaceuticals Inc141,000141,0000$7.21M$7.21M9.64%+$4.2K
Rallybio Corporation(RLYB)3,301,6033,301,6030$3.86M$3.17M4.24%-$693.3K
Cogent Biosciences, Inc.(COGT)250,765250,7650$2.71M$1.96M2.61%-$752.3K
Rocket Pharmaceuticals, Inc.(RCKT)150,706150,7060$2.78M$1.89M2.53%-$889.2K
Passage Bio, Inc.(PASG)2,497,9222,497,9220$1.75M$1.42M1.89%-$332.2K
Alector Inc339,569339,5690$1.58M$641.8K0.86%-$940.6K
Iterum Therapeutics PlcSHS345,020345,0200$376.1K$610.7K0.82%+$234.6K
X4 Pharmaceuticals, Inc.(XFOR)335,0000-335,000$224.1K$0—-$224.1K
Page 1 of 1
New Leaf Venture Partners, L.L.C. — 13F Holdings — Q4 2024 | TickerTrail